Equities analysts predict that Innophos Holdings, Inc. (NASDAQ:IPHS) will report earnings of $0.56 per share for the current quarter, according to Zacks. Zero analysts have issued estimates for Innophos’ earnings. Innophos reported earnings per share of $0.52 during the same quarter last year, which would suggest a positive year-over-year growth rate of 7.7%. The company is scheduled to report its next earnings results on Tuesday, February 20th.

According to Zacks, analysts expect that Innophos will report full year earnings of $2.50 per share for the current financial year. For the next year, analysts expect that the company will post earnings of $2.75 per share. Zacks’ earnings per share averages are a mean average based on a survey of sell-side analysts that that provide coverage for Innophos.

Innophos (NASDAQ:IPHS) last released its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.78 earnings per share for the quarter, beating the consensus estimate of $0.72 by $0.06. The business had revenue of $184.00 million for the quarter, compared to analyst estimates of $179.33 million. Innophos had a return on equity of 13.90% and a net margin of 6.19%. The company’s revenue was down 1.1% compared to the same quarter last year. During the same period in the previous year, the company posted $0.69 EPS.

IPHS has been the topic of several analyst reports. Zacks Investment Research upgraded Innophos from a “hold” rating to a “strong-buy” rating and set a $54.00 target price on the stock in a report on Tuesday, August 8th. KeyCorp reiterated a “hold” rating on shares of Innophos in a report on Wednesday, November 1st. Finally, BidaskClub downgraded Innophos from a “hold” rating to a “sell” rating in a report on Tuesday.

Large investors have recently made changes to their positions in the stock. Public Employees Retirement System of Ohio increased its holdings in Innophos by 379.3% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 13,535 shares of the specialty chemicals company’s stock worth $666,000 after purchasing an additional 10,711 shares during the last quarter. GSA Capital Partners LLP increased its holdings in Innophos by 131.1% during the 3rd quarter. GSA Capital Partners LLP now owns 19,492 shares of the specialty chemicals company’s stock worth $959,000 after purchasing an additional 11,059 shares during the last quarter. Piedmont Investment Advisors LLC purchased a new stake in Innophos during the 3rd quarter worth approximately $209,000. Highbridge Capital Management LLC purchased a new stake in Innophos during the 3rd quarter worth approximately $265,000. Finally, Segall Bryant & Hamill LLC increased its holdings in Innophos by 11.0% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 820,518 shares of the specialty chemicals company’s stock worth $40,361,000 after purchasing an additional 81,550 shares during the last quarter. Institutional investors and hedge funds own 94.46% of the company’s stock.

Innophos (NASDAQ:IPHS) opened at $46.22 on Wednesday. The firm has a market capitalization of $901.46, a PE ratio of 18.78 and a beta of 0.85. The company has a quick ratio of 1.49, a current ratio of 2.86 and a debt-to-equity ratio of 0.83. Innophos has a 52 week low of $41.66 and a 52 week high of $58.22.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 6th. Investors of record on Friday, November 17th will be issued a dividend of $0.48 per share. The ex-dividend date is Thursday, November 16th. This represents a $1.92 annualized dividend and a dividend yield of 4.15%. Innophos’s payout ratio is currently 88.07%.

COPYRIGHT VIOLATION WARNING: This article was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another domain, it was copied illegally and reposted in violation of international copyright and trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/12/06/zacks-analysts-expect-innophos-holdings-inc-iphs-will-post-earnings-of-0-56-per-share.html.

About Innophos

Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.

Get a free copy of the Zacks research report on Innophos (IPHS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.